BUB1B promotes homologous recombination‑mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway
Oncology Reports · 01.09.2025 · 54 (5) · 1-13
DOI: 10.3892/or.2025.8980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 01.09.2025. Verfasst von Xuewen Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Medical University Graduate School, Nanning, Guangxi 530021, P.R. China. Hauptthemen laut MEDLINE: Breast Neoplasms, Protein Serine-Threonine Kinases, Recombinational DNA Repair, Cell Cycle Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Medical University Graduate School, Nanning, Guangxi 530021, P.R. China.
- Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530007, P.R. China.
Zitieren
APA
Luo, X., Wei, Y., Lin, H., Xiao, N., & Zhao, W. (2025). BUB1B promotes homologous recombination‑mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway. Oncology Reports, 54(5), 1-13. https://doi.org/10.3892/or.2025.8980
Vancouver
Luo X, Wei Y, Lin H, Xiao N, Zhao W. BUB1B promotes homologous recombination‑mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway. Oncology Reports. 2025;54(5):1-13. doi:10.3892/or.2025.8980
BibTeX
@article{Luo2025,
author = {Luo, Xuewen and Wei, Yuqin and Lin, Hanxin and Xiao, Ning and Zhao, Wei},
title = {BUB1B promotes homologous recombination‑mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway},
journal = {Oncology Reports},
year = {2025},
volume = {54},
number = {5},
pages = {1--13},
doi = {10.3892/or.2025.8980}
}
EUVIMED